Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Genoveffa Franchini

Showing results (121-130 of 165) with videos related to

Pageof 17
Sort By:
Immunity|December 14, 2004
T cell receptor recognition motifs govern immune escape patterns in acute SIV infectionDavid A Price, Sadie M West, Michael R Betts, et al.
Plos Pathogens|August 13, 2015
Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal ChallengeIskra Tuero, Venkatramanan Mohanram, Thomas Musich, et al.
Journal of Virology|December 26, 2001
Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infectionBianca R Mothé, Helen Horton, Donald K Carter, et al.
Frontiers in Immunology|February 6, 2026
Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccineKasey Stokdyk, Anusmita Sahoo, Sailaja Gangadhara, et al.
Frontiers in Immunology|May 8, 2023
Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIV<sub>mac251</sub> acquisition in macaquesMohammad Arif Rahman, Manuel Becerra-Flores, Yury Patskovsky, et al.
Journal of Virology|March 31, 2006
Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levelsRanajit Pal, David Venzon, Sampa Santra, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2020
The V2 loop of HIV gp120 delivers costimulatory signals to CD4<sup>+</sup> T cells through Integrin α<sub>4</sub>β<sub>7</sub> and promotes cellular activation and infectionLivia R Goes, Alia Sajani, Aida Sivro, et al.
The Journal of Infectious Diseases|January 6, 2005
Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challengeYvette Edghill-Smith, Mike Bray, Chris A Whitehouse, et al.
Plos Pathogens|November 7, 2014
Co-dependence of HTLV-1 p12 and p8 functions in virus persistenceCynthia A Pise-Masison, Maria Fernanda de Castro-Amarante, Yoshimi Enose-Akahata, et al.
AIDS Research and Human Retroviruses|January 18, 2014
Glucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoirMarcin Moniuszko, Namal P M Liyanage, Melvin N Doster, et al.
Pageof 17

Showing results (121-130 of 165) with videos related to

Sort By:
Pageof 17
Immunity|December 14, 2004
T cell receptor recognition motifs govern immune escape patterns in acute SIV infectionDavid A Price, Sadie M West, Michael R Betts, et al.
Plos Pathogens|August 13, 2015
Mucosal B Cells Are Associated with Delayed SIV Acquisition in Vaccinated Female but Not Male Rhesus Macaques Following SIVmac251 Rectal ChallengeIskra Tuero, Venkatramanan Mohanram, Thomas Musich, et al.
Journal of Virology|December 26, 2001
Dominance of CD8 responses specific for epitopes bound by a single major histocompatibility complex class I molecule during the acute phase of viral infectionBianca R Mothé, Helen Horton, Donald K Carter, et al.
Frontiers in Immunology|February 6, 2026
Immunogenicity and protection mediated by dmLT and alum adjuvants for an HIV-1 vaccineKasey Stokdyk, Anusmita Sahoo, Sailaja Gangadhara, et al.
Frontiers in Immunology|May 8, 2023
Cholera toxin B scaffolded, focused SIV V2 epitope elicits antibodies that influence the risk of SIV<sub>mac251</sub> acquisition in macaquesMohammad Arif Rahman, Manuel Becerra-Flores, Yury Patskovsky, et al.
Journal of Virology|March 31, 2006
Systemic immunization with an ALVAC-HIV-1/protein boost vaccine strategy protects rhesus macaques from CD4+ T-cell loss and reduces both systemic and mucosal simian-human immunodeficiency virus SHIVKU2 RNA levelsRanajit Pal, David Venzon, Sampa Santra, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 8, 2020
The V2 loop of HIV gp120 delivers costimulatory signals to CD4<sup>+</sup> T cells through Integrin α<sub>4</sub>β<sub>7</sub> and promotes cellular activation and infectionLivia R Goes, Alia Sajani, Aida Sivro, et al.
The Journal of Infectious Diseases|January 6, 2005
Smallpox vaccine does not protect macaques with AIDS from a lethal monkeypox virus challengeYvette Edghill-Smith, Mike Bray, Chris A Whitehouse, et al.
Plos Pathogens|November 7, 2014
Co-dependence of HTLV-1 p12 and p8 functions in virus persistenceCynthia A Pise-Masison, Maria Fernanda de Castro-Amarante, Yoshimi Enose-Akahata, et al.
AIDS Research and Human Retroviruses|January 18, 2014
Glucocorticoid treatment at moderate doses of SIVmac251-infected rhesus macaques decreases the frequency of circulating CD14+CD16++ monocytes but does not alter the tissue virus reservoirMarcin Moniuszko, Namal P M Liyanage, Melvin N Doster, et al.
Pageof 17